JAMES LEE to Purinergic P2Y Receptor Antagonists
This is a "connection" page, showing publications JAMES LEE has written about Purinergic P2Y Receptor Antagonists.
Connection Strength
0.047
-
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2023 03; 113(3):615-623.
Score: 0.047